Lisinopril EP Impurity C

(2S)-2-[(3S,8aS)-3-(4-Aminobutyl)-1,4-dioxohexahydropyrrolo[1,2-a]pyrazin-2(1H)-yl]-4-phenylbutanoic Acid;|(2S)-2-[(3S,8aS)-3-(4-Aminobutyl)-1,4-dioxohexahydropyrrolo[1,2-a]pyrazin-2(1H)-yl]-4-phenylbutaperazine|(S)-2-((3S,8aS)-3-(4-aminobutyl)-1,4-dioxohexahydropyrrolo[1,2-a]pyrazin-2(1H)-yl)-4-phenylbutanoic acid|(S)-2-((3S,8aS)-3-(4-Aminobutyl)-1,4-dioxohexahydropyrrolo[1,2-a]pyrazin-2(1H)-yl)-4-phenylbutanoic acid, hydrochloride (1:1)|Lisinopril EP Impurity C ; Lisinopril USP Related Compound A ; Lisinopril (S,S,S)-Diketopiperazine ; (2S)-2-[(3S,8aS)-3-(4-Aminobutyl)-1,4-dioxohexahydropyrrolo[1,2-a]pyrazin-2(1H)-yl]-4-phenylbutano|Lisinopril EP Impurity C HCl ((S,S,S)-Diketopiperazine HCl)|Lisinopril Related Compound A|S,S,S-Diketopiperazine (lisinopril related compound A) ;